Las Vegas, NV -- (SBWIRE) -- 10/24/2013 -- EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more .EquityObserver.com issues a special report on the following stocks: La Jolla Pharmaceutical Company (OTCBB: LJPC), El Capitan Precious Metals, Inc. (OTCBB: ECPN), Exide Technologies (OTCMKTS: XIDEQ), Genspera Inc (OTCMKTS: GNSZ)
La Jolla Pharmaceutical Company (OTCBB: LJPC) managed to keep its fall at -6.34% on above-normal volume of 958,828.00 shares. The stock settled at $0.192 after floating in a range of $0.19 to $0.22. Its latest price has reached market capitalization of $5.86 million. Its 52-week range has been $0.04 to $0.24. La Jolla Pharmaceutical Company is a biopharmaceutical company. The Company is focused on the development of treatments that inhibits the activity of galectins as a means of treating human diseases, such as cancer and chronic organ failure.
Has LJPC Found The Bottom and Ready To Move Up? Find Out Here
El Capitan Precious Metals, Inc. (OTCBB: ECPN) traded down/ on a volume of 553,490.00, higher than its standard daily volume. Shares have dropped-16.28% to $0.180. Over the last twelve months, the stock has lost-54.53% and faced a worst price of $0.05. El Capitan Precious Metals, Inc. (ECPN) is an exploration-stage company. The Company is a precious minerals company based in Scottsdale.
Has ECPN Found The Bottom And Ready To Gain Momentum? Find Out Here
Exide Technologies (OTCMKTS: XIDEQ) settled 4.12% /lower at $0.354 on below -normal volume of 778,075.00 shares during the last trading day. The stock has its 12-month high at $3.75 and 52-week low price was $0.11. It traded in a range of $0.34 to $0.35 during the last trading day. Exide Technologies (Exide) is engaged in stored electrical energy solutions, and is a manufacturer and supplier of lead-acid batteries for transportation and industrial applications in the worldwide. Exide operates in four business segments:
Why Should Investors Buy XIDEQ After the Recent Fall? Just Go Here and Find Out
In the last trading session, Genspera Inc (OTCMKTS: GNSZ) was down on high volume, trading at a volume of 43,700.00 versus its average daily volume of 12,796.00 shares. At $1.40, the stock has attained market capitalization of 33.46 million. GenSpera Inc. (GenSpera) is a development-stage company. The Company is a pharmaceutical company focused on the development of targeted cancer therapeutics for the treatment of cancerous tumors, including breast.
Why Should Investors Buy GNSZ sAfter the Recent Fall? Just Go Here and Find Out
About Equity Observer:
Equity Observer delivers intra-day insights into the equities, tech and investment world. The website is a window into what’s going on in the business world and why.
EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
http://www.equityobserver.com/ has a no tolerance spam policy; we will not sell or re-distribute your email to any 3rd party. A If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members.
PLEASE NOTE WELL: The http://www.equityobserver.com/" rel="nofollow" href="http://www.equityobserver.com/"> http://www.equityobserver.com/>
Employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Read Full Disclaimer at: http://www.equityobserver.com/
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)